Produkty 2129515-96-2

CAS 2129515-96-2 występuje w naszej ofercie pod nazwami: Vepafestinib/ 98.58% (existing batch purity), Vepafestinib, Vepafestinib, 98.61%, Vepafestinib, 98%, 4-Amino-N-(4-(methoxymethyl)phenyl)-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide. Oferty producentów: TargetMol, GLPBio, MedChemExpress, Ambeed, Chemat. Dostępne opakowania: 1mg, 5mg, 10mg, 10mM (in 1ml dmso), 10 mg, 100 mg, 25 mg, 50 mg.

Vepafestinib/ 98.58% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 1030,12
Zobacz produkt
Vepafestinib
GLPBio
  • opakowanie: 1mg, 10mg, 5mg, 10mM (in 1ml dmso)
  • Warianty: 4
od 1238,27
Zobacz produkt
Vepafestinib, 98.61%
MedChemExpress
  • opakowanie: 10 mg, 100 mg, 25 mg, 50 mg
  • Warianty: 6
od 2037,97
Zobacz produkt
Vepafestinib, 98%
Ambeed
  • opakowanie: 100mg, 250mg
  • Warianty: 2
od 7690,62
Zobacz produkt
4-Amino-N-(4-(methoxymethyl)phenyl)-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
Chemat
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 3
od 1163,60
Zobacz produkt
4-Amino-N-(4-(methoxymethyl)phenyl)-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide, 98%
BLDpharm
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 6
od 991,90
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

4-amino-N-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholin-4-ylprop-1-ynyl)pyrrolo[2,3-d]pyrimidine-5-carboxamide (CAS 2129515-96-2) to związek chemiczny o wzorze sumarycznym C26H30N6O3 i masie molowej 474.6 g/mol. Nazwa systematyczna IUPAC: 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholin-4-ylprop-1-ynyl)pyrrolo[2,3-d]pyrimidine-5-carboxamide. InChIKey: SFXVRNLGOSAWIV-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H30N6O3
Masa molowa474.6 g/mol
Nazwa IUPAC4-amino-N-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholin-4-ylprop-1-ynyl)pyrrolo[2,3-d]pyrimidine-5-carboxamide
InChIKeySFXVRNLGOSAWIV-UHFFFAOYSA-N
SMILESCC1(CC1)N2C(=C(C3=C(N=CN=C32)N)C(=O)NC4=CC=C(C=C4)COC)C#CCN5CCOCC5

Dane obliczone przez PubChem (NCBI)

Synonimy: vepafestinib, Vepafestinib [INN], example 85 [US20180009818A1], example 85 (US20180009818A1), RET Inhibitor TAS0953/HM06, Ex. Cpd. 85, Vepafestinib [WHO-DD], orb1685295, orb2900261
Izomery (ten sam wzór sumaryczny)
N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide C26H30N6O3
ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate C26H30N6O3
N-[1-[[(cyanoamino)-(quinolin-5-ylamino)methylidene]amino]-2,2-dimethylpropyl]-2-(3,4-dimethoxyphenyl)acetamide C26H30N6O3
2-[2-ethoxy-4-(4-hydroxypiperidin-1-yl)anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one C26H30N6O3
N-methyl-3-[2-[(3S)-3-methylmorpholin-4-yl]-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrido[2,3-d]pyrimidin-7-yl]benzamide C26H30N6O3
[(3S,4R)-3-amino-4-hydroxypiperidin-1-yl]-[2-[1-(cyclopropylmethyl)pyrrolo[2,3-b]pyridin-2-yl]-7-methoxy-1-methylbenzimidazol-5-yl]methanone C26H30N6O3
2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide C26H30N6O3